Humulin r and Fluid retention - a phase IV clinical study of FDA data

Summary:

Fluid retention is found among people who take Humulin r, especially for people who are female, 60+ old, have been taking the drug for 2 - 5 years.

The phase IV clinical study analyzes which people take Humulin r and have Fluid retention. It is created by eHealthMe based on reports of 20,849 people who have side effects when taking Humulin r from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Feb, 07, 2023

20,849 people reported to have side effects when taking Humulin r.
Among them, 163 people (0.78%) have Fluid retention.

What is Humulin r?

Humulin r has active ingredients of insulin recombinant human. It is often used in type 1 diabetes. eHealthMe is studying from 20,918 Humulin r users for its effectiveness, alternative drugs and more.

What is Fluid retention?

Fluid retention (an abnormal accumulation of fluid in the blood) is found to be associated with 3,107 drugs and 2,257 conditions by eHealthMe.

Number of Humulin r and Fluid retention reports submitted per year:

* Approximation only. Some reports may have incomplete information.

Do you take Humulin r and have Fluid retention?

Check whether Fluid retention is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Fluid retention and when was it recovered:

Fluid retention in Humulin r

Expand to all the drugs that have ingredients of insulin recombinant human:

Fluid retention and drugs with ingredients of insulin recombinant human

Alternative drugs to, pros and cons of Humulin r:

Humulin r (20,918 reports)

Common Humulin r side effects:

Drug ineffective: 1,623 reports
Diabetes: 1,073 reports
Heart attack: 883 reports
Weight increased: 847 reports
High blood pressure: 774 reports

Browse all side effects of Humulin r:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Fluid retention treatments and more:

Fluid retention (71,367 reports)

COVID vaccines that are related to Fluid retention:

Common drugs associated with Fluid retention:

All the drugs that are associated with Fluid retention:

Fluid retention (3,107 drugs)

Common conditions associated with Fluid retention:

Primary pulmonary hypertension: 10,026 reports
Rheumatoid arthritis: 2,053 reports
High blood pressure: 1,924 reports
Multiple myeloma: 1,326 reports
Diabetes: 1,318 reports
Pain: 1,296 reports

All the conditions that are associated with Fluid retention:

Fluid retention (2,257 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on insulin recombinant human (the active ingredients of Humulin r) and Humulin r (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.